The SphygmoCor CP system acquires the patient’s radial pulse waveform noninvasively by applanation tonometry.
Critical cardiovascular measurements include:
- Aortic Augmentation Index and Pressure
- Ejection Duration
- Subendocardial Viability Ratio
The system may facilitate early identification of cardiovascular risk, and is essential for the management of patients with hypertension, diabetes, diastolic heart failure, and other high cardiovascular risk conditions such as renal disease and hypercholesterolaemia.
SphygmoCor CP Applications:
- Evaluation of arterial stiffness and its clinical impact
- Improved patient evaluation in hypertension, diabetes and cardiac failure
- Early identification of "at risk" diabetes patients
- Monitoring at the heart of the effect of drug intervention
Features:
- Coronary artery perfusion pressure throughout the cardiac cycle
- Instantaneous calculation of key parameters,including
- - Aortic Pulse Pressure
- - Aortic Systolic Pressure
- - Aortic Systolic Pressure
- - Aortic Augmentation Index
- - Left ventricular load
- - Pulse pressure in the left ventricle and in the ascending aorta (driving cerebral blood flow)
- - Central systolic pressure (as seen by the baro-receptors), which can be markedly different from the cuff value
- - Ejection duration in relation to cardiac cycle
- Evaluation of arterial stiffness and its clinical impact on the heart
- A powerful index of subendocardial viability
- Automatic, real-time QA feedback leading to minimal operator variability
- Noninvasive test
Benefits:
- Central pressure has been shown to be a superior,independent predictor of future cardiovascular events than peripheral pressure
- Allows assessment of drug effects that cannot be detected with brachial pressure measurements
- Provides patients with visual evidence of the effects of lifestyle changes and drug therapies
- comfortable for patients
- No disposables required